OPKO Health, Inc. (TLV: OPK)

Market Cap	4.19B
Revenue (ttm)	2.64B
Net Income (ttm)	-497.13M
Shares Out	n/a
EPS (ttm)	-0.72
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	375,052
Open	624.00
Previous Close	622.70
Day's Range	607.50 - 629.90
52-Week Range	315.00 - 639.80
Beta	1.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 7, 2024

About OPKO Health

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company’s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women’s health, and correctional healthcare to physician offices, clinics, hospitals, employers,...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2007
• Employees: 3,930
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: OPK

Financial Performance

In 2023, OPKO Health's revenue was $863.50 million, a decrease of -14.01% compared to the previous year's $1.00 billion. Losses were -$188.86 million, -42.49% less than in 2022.

Financial numbers in USD